Clearwater Analytics Holdings, Inc. CWAN 深 沪
已收盘 10-31 16:00:00 美东时间
18.41
+0.220
+1.21%
华盛通- 最 高18.46
- 今 开18.05
- 成交量 433.04万股
- 最 低 18.01
- 昨 收 18.19
- 总市值 53.02亿
- 52周最高 32.71
- 市盈率 静 11.03
- 换手率 1.50%
- 52周最低 17.15
- 委 比 96.72%
- 总股本 2.88亿
- 历史最高 35.71
- 量 比 1.07
- 振 幅 2.47%
- 历史最低 11.23
- 每 手 1
- 风险率 4.18%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Clearwater Analytics, .P. Morgan Asset Management To Integrate Clearwater's Enfusion With Morgan Money To Offer Automated Workflow For Investing, Overseeing Idle Cash
Clearwater Analytics (NYSE: CWAN), the most comprehensive technology platform for investment management, and J.P. Morgan Asset Management today announced an integration that transforms how hedge funds manage cash. The
10-23 21:11
美股大行评级 | Tigress Financial：维持苹果"强烈买入"评级，目标价升至305美元；杰富瑞维持百度"买入"评级，目标价升至157美元
今日重点评级关注：HC Wainwright & Co.：维持Astria Therapeutics"买入"评级，目标价从16美元升至20美元；HC Wainwright & Co.：维持Avalo Therapeutics"买入"评级，目标价从15美元升至25美元
09-18 10:13
RBC Capital Reiterates Outperform on Clearwater Analytics Hldg, Maintains $36 Price Target
RBC Capital analyst Rishi Jaluria reiterates Clearwater Analytics Hldg (NYSE:CWAN) with a Outperform and maintains $36 price target.
09-17 22:10
Clearwater Analytics Authorizes $100M Share Repurchase Program
Clearwater Analytics (NYSE:CWAN) ("CWAN" or "Company"), the most comprehensive technology platform for investment management, today announced that its Board of Directors has authorized a $100 million share repurchase
09-04 02:59
美股大行评级 | 潜在涨幅921.1%！Intensity Therapeutics获Brookline Capital升级至"买入"，目标价上调至3美元
今日重点评级关注：Brookline Capital：上调Intensity Therapeutics评级至"买入"，目标价3美元；Chardan Capital：维持Taysha Gene Therapies"买入"评级，目标价从9美元升至10美元
08-13 09:10
Clearwater Analytics Holdings shares are trading lower after the company reported Q2 financial results and issued Q3 sales guidance below estimates.
Clearwater Analytics Holdings shares are trading lower after the company report...
08-07 22:24
Clearwater Analytics Hldg Raises FY2025 Sales Guidance from $720.000M-$728.000M to $726.000M-$732.000M vs $724.024M Est
Clearwater Analytics Hldg (NYSE:CWAN) raises FY2025 sales outlook from $720.000 million-$728.000 million to $726.000 million-$732.000 million vs $724.024 million estimate.
08-07 04:19
Clearwater Analytics Hldg Q2 Adj. EPS $0.12, Inline, Sales $181.937M Beat $174.125M Estimate
Clearwater Analytics Hldg (NYSE:CWAN) reported quarterly earnings of $0.12 per share which met the analyst consensus estimate. This is a 20 percent increase over earnings of $0.10 per share from the same period last
08-07 04:18
Earnings Scheduled For August 6, 2025
Companies Reporting Before The Bell • Lineage (NASDAQ:LINE) is likely to report...
08-06 16:33
P/E Ratio Insights for Clearwater Analytics Hldg
In the current market session, Clearwater Analytics Hldg Inc. (NYSE:CWAN) share...
07-23 01:00
